Blog

iReceptor Plus presented at immunotherapy, immunogenetics and bioinformatics experts meeting in San Diego

29/01/2020

By Judy Siegel-Itzkovich

Over 900 experts in immunotherapy, immunogenetics and bioinformatics met in San Diego in December 2019 at the official meeting of the Antibody Engineering and Therapeutics meeting. It is the official meeting of The Antibody Society (TAbS), which is the umbrella organization for the AIRR Community, an important partner of the iReceptor Plus Consortium.

This event – with more than 135 speakers, over 75 exhibitors and over 135 scientific posters – focused on antibody science and technology and was an impressive combination of academic and industrial experts in the three fields.

The meetings were regarded as a great success for iReceptor Plus and the antibody community as a whole. In December 2020, the AIRR Community will meet in La Jolla, CA in conjunction with the Antibody Engineering and Therapeutics meeting, as well as with members of the iReceptor Plus consortium.

The TAbS website described it as “the global meeting place for antibody science, technology and networking. Given the enormous potential for translational medicine represented by antibodies, the annual Antibody Engineering Meeting is an important venue for meeting new collaborators and partners, and iReceptor Plus was well represented at the 2019 meetings.”

Dr. Sarah Taylor, staff scientist at 10X Genomics – an iReceptor Plus partner – presenting at the Antibody Engineering and Therapeutics meeting.
Dr. Sarah Taylor, staff scientist at 10X Genomics – an iReceptor Plus partner – presenting at the Antibody Engineering and Therapeutics meeting.


Dr. Sarah Taylor
, staff scientist at 10X Genomics – one of the industrial partners of the iReceptor Plus Consortium – spoke at Jamie Scott’s “Systems Immunology for Therapeutic Target Discovery” symposium on Single Cell Multiomic Characterization of Antigen Specific CD8 T cells at Scale.”

She discussed the Single Cell Immune Profiling platform that will be an important component of the iReceptor Plus single cell roll out.

Prof. Felix Breden, iReceptor Plus scientific manager, presented a poster entitled, iReceptor Plus: a data integration platform to share, compare and analyze Adaptive Immune Receptor Repertoire (AIRR-seq) data,” aimed at encouraging people to use the Gateway.

Ms. Pam Borghardt, iReceptor administrative director, coordinates the efforts across the iReceptor Plus project, The Antibody Society and the AIRR Community